The race to develop treatments and a vaccine for COVID-19 highlights the value of repurposing solutions.
Georg von Krogh, Burcu Kucukkeles, and Shiko M. Ben-Menahem
What’s New from Frontiers
Daniel Z. Levin and Terri R. Kurtzberg
(Re)Learn to Lead
How leadership is evolving in a digital world.Read the full series
More Insights from MIT SMR’s Frontiers
Pharma’s existing model may be a liability in the race to develop drugs and vaccines to combat COVID-19.
Markus Scholz and N. Craig Smith
To innovate and survive, organizations must develop core business skills in their digital talent.